Simplex Trading, LLC Tyra Biosciences, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$14.45 - $20.22 $592 - $829	-41 Reduced 41.0%	59 $0
Q1 2024 Apr 25, 2024	BUY	$11.61 - $20.0 $1,161 - $2,000	100 New	100 $1,000
Q3 2023 Nov 01, 2023	BUY	$13.15 - $16.08 $17,555 - $21,466	1,335 Added 198.07%	2,009 $27,000
Q2 2023 Aug 04, 2023	BUY	$11.99 - $17.51 $8,081 - $11,801	674 New	674 $11,000

43.5M

353K

1.1K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $588M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.